Finnish medtech startup AIATELLA has raised €2M in funding led by Nordic Science Investments to develop its AI-powered cardiovascular imaging technology.
The company aims to automate manual processes in medical imaging and move towards preventative cardiovascular care.
AIATELLA's multi-modal Automated Image Measurement (AIM) technology analyzes vascular imaging and provides precise measurements for clinical decision-making.
The company is developing an ultrasound-based portable screening technology for mass screening of at-risk populations.
AIATELLA focuses on diverse demographic representation in its AI imaging technology for more accurate diagnoses across different populations.
The portable screening technology aims to improve access to early detection of cardiovascular diseases, especially in underserved communities.
AIATELLA is conducting clinical trials and seeking regulatory approvals for its technology in various countries.
The company believes in supporting radiologists by automating routine tasks and allowing them to focus on high-value clinical work.
AIATELLA's goal is to reshape hospital workflows to prioritize clinical thinking over manual labor with the help of AI technology.
The company's technology has already been used in Finland and the UK to identify individuals at risk of cardiovascular diseases for further evaluation.